Juicero
Juicero was a company based in San Francisco, California, that sold a juicer connected to the Internet which was designed to squeeze packets of pre-juiced fruits and vegetables, sold by the company, to produce juice at home. The company was founded by Doug Evans in 2013, with the Juicero system officially launching in March 2016. Despite initial hype and substantial investment, Juicero became controversial for the high cost of the juicer, the proprietary juice packets required to use it, and revelations that the packets could be squeezed by hand without using the device. The company ceased operations in September 2017.
History
Juicero was established with the vision of revolutionizing home juicing by making it easier and more accessible to consumers. The company raised over $120 million from various investors, including Kleiner Perkins Caufield & Byers, Google Ventures, and other high-profile entities. The Juicero juicer was initially priced at $699, which was later reduced to $399 in response to criticism over its high cost.
Product
The Juicero juicer was a complex piece of machinery, approximately the size of a small kitchen appliance. It connected to the internet to download the pressing instructions for each specific juice packet, which contained pre-chopped fruits and vegetables. The device used a powerful press to squeeze the packets, which were sold via subscription by Juicero, producing a glass of juice. The company touted the freshness of its produce and the convenience of the system, which required no preparation or cleanup beyond placing the packet in the machine and starting the press.
Controversy
The Juicero system came under scrutiny in April 2017 when Bloomberg published a report showing that the juice packets could be squeezed by hand, without the need for the expensive Juicero machine. This revelation led to widespread mockery and criticism, questioning the necessity and value of the Juicero system. In response, Juicero offered refunds to all customers who requested them.
Closure
Despite efforts to revitalize the company by reducing the cost of the juicer and offering refunds, Juicero announced it was suspending operations in September 2017. The company cited the inability to lower costs to a sustainable level and the challenges of scaling a fresh food company as reasons for its closure.
Legacy
Juicero is often cited as an example of Silicon Valley excess and the pitfalls of venture capital investment in technology startups without sufficient market validation. The story of Juicero serves as a cautionary tale about the importance of product-market fit and the risks of over-engineering solutions to simple problems.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD